Evommune, Inc. (EVMN)

Evommune, Inc. (EVMN) is a healthcare company (biotechnology) based in the United States. The share price is $7.11, up 0.14% on the day, which values the company at $294M. Price as of 17 Nov 2026, 19:16 UTC, from Yahoo Finance.

Key facts

Share price
$7.11+0.14% today
Market value
$294M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Evommune, Inc. in more detail

EVMN trades at -2.1× next year's expected earnings.

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Heavy stock-based pay.

2 of the superinvestors tracked here hold EVMN, including Peter Kolchinsky (0.4% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding EVMN

2 of the investors tracked here report a position in their latest 13F filing.

Evommune, Inc. (EVMN): questions and answers

What is Evommune, Inc.'s market cap?

Evommune, Inc. is valued at $294M at a share price of $7.11.

Does EVMN pay a dividend?

Evommune, Inc. does not currently pay a regular dividend.

Which famous investors own EVMN?

In their latest quarterly filings, Peter Kolchinsky (0.4% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold EVMN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

When does Evommune, Inc. report earnings next?

Evommune, Inc.'s next earnings report is expected on November 16, 2026. The date comes from the market data feed and companies do move it.

Cite this page

Funkfolio, “Evommune, Inc. (EVMN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EVMN

Underlying data: Yahoo Finance; company filings with the SEC.